Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$113.42 - $156.48 $2,495 - $3,442
-22 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$121.55 - $156.8 $2,674 - $3,449
22 New
22 $3,000
Q2 2018

Aug 13, 2018

SELL
$112.2 - $165.95 $7,068 - $10,454
-63 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$84.6 - $126.1 $5,329 - $7,944
63 New
63 $7,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.